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Abstract 
Background: Protein arginine methylation is a prevalent post‑translational modification. The protein arginine meth‑
yltransferase family (PRMT) is involved in many cellular processes in eukaryotes, including transcriptional regulation, 
epigenetic regulation, RNA metabolism, and DNA damage repair. Toxoplasma gondii, an opportunistic protozoan 
parasite, encodes five conserved PRMTs. PRMT5 is thought to be responsible for substantial PRMT activity in T. gondii; 
however, it has not yet been characterized.
Methods: We tagged the 3′ end of the endogenous TgPRMT5 genomic locus with sequence encoding a 3X hemag‑
glutinin (HA) epitope. IFA and WB were performed to check the expression and subcellular localization of TgPRMT5 in 
tachyzoites and bradyzoites. In vitro methylation assays were performed to determine whether endogenous TgPRMT5 
has arginine methyltransferase activity.
Results: IFA and WB results showed that T. gondii PRMT5 (TgPRMT5) was localized in the cytoplasm in the tachyzoite 
stage; however, it shifts largely to the nuclear compartment in the bradyzoite stage. The in vitro methylation showed 
that TgPRMT5 has authentic type II PRMT activity and forms monomethylarginines and symmetric dimethylarginines.
Conclusions: We determined the expression and cellular localization of TgPRMT5 in tachyzoites and bradyzoites 
and confirmed its type II PRMT activity. We demonstrated the major changes in expression and cellular localization of 
TgPRMT5 during the tachyzoite and bradyzoite stages in T. gondii. Our findings suggest that TgPRMT5 protein may be 
involved in tachyzoite‑bradyzoite transformation.
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Background
Toxoplasma gondii (T. gondii) is an obligate intracellu-
lar parasite of the phylum Apicomplexa. This species is 
the causative agent of toxoplasmosis, which is estimated 
to infect 16–40% of the population of the USA and up 
to 80% of the population in other countries [1]. Toxo-
plasma gondii can differentiate from a rapidly replicat-
ing tachyzoite stage to a latent cyst form, the bradyzoite 
stage. Bradyzoite cysts can remain in tissues of the host 
for its lifetime without health consequences. However, 
when the host immunity is attenuated, bradyzoites can 
revert to actively replicating tachyzoites, causing life-
long chronic infection. Thus, understanding the molecu-
lar mechanisms underpinning conversion between these 
stages may identify novel targets for clinical treatment.
Stage-specific gene expression is controlled by the 
concerted actions of specific transcription factors 
and repressors, translational repression, and epige-
netic mechanisms [2]. Significant alterations in the 
expressed transcriptome and remodeling of chromatin 
structure, a major mechanism restricting and regulat-
ing access to genomic DNA, are occurring during the 
conversion between the tachyzoite and bradyzoite 
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stages. Toxoplasma gondii has a full complement of 
histone-modifying enzymes, histones and variants 
[3]. Characterization of the T. gondii histone-modi-
fying enzymes will provide a better understanding of 
the role of epigenetic regulation in gene expression in 
pathogenic apicomplexan parasites like T. gondii.
Gene expression can be negatively or positively mod-
ulated by methylation of arginine and lysine residues 
in histones. Moreover, both arginine and lysine meth-
yltransferases are proposed to play an important role 
of gene expression regulators in T. gondii [4].
Structurally, each protein arginine methyltransferase 
family (PRMT) shares a conserved methyltransferase 
domain with subdomains for binding to S-adenosyl-
L-methionine (SAM), a methyl donor and substrate 
proteins. Five putative arginine methyltransferases 
have been revealed by the bioinformatic analysis of 
the Toxoplasma genome sequence (http://www.toxod 
b.org) [5], and two PRMTs have been characterized in 
T. gondii [4–6]. PRMT1 (TGME49_219520) is reported 
to mediate methylation of arginine 3 of H4, while 
PRMT4 (TgCARM1) catalyzes methylation of arginine 
17 of H3 and has been attributed to gene activation [5]. 
PRMT5 is a type II methyltransferase associated with 
transcriptional repression in other species [7, 8]. It is 
associated with multiple protein complexes and medi-
ates diverse functions including RNA processing, tran-
scriptional regulation, and muscle as well as germ line 
differentiation [9]. However, in T. gondii, the functions 
of PRMT5 remain poorly understood.
Here, we report the identification and characteriza-
tion of the PRMT5 homolog, referred as TgPRMT5, 
in T. gondii. TgPRMT5 (TGGT1_215560) is located 
on chromosome X, spans 2940 bp, and contains no 
introns. It encodes a protein of 979 amino acids with 
a predicted molecular mass of 107 kDa. The PROS-
ITE database (http://us.expas y.org/prosi te/) was used 
to search for predicted protein motifs in TgPRMT5. 
TgPRMT5 contains a conserved SAM-dependent 
methyltransferase PRMT-type domain as the PROS-
ITE database showing it ranging from 601 to 957 
amino acids. TgPRMT5 is an evolutionarily conserved 
protein with type II PRMT activity toward histone 
H3 arginine-26 (H3R26) and histone H4 arginine-3 
(H4R3). Mammalian PRMT5 localizes to both the 
cytoplasm and the nucleus [10]. It has been proposed 
that PRMT5 relocates from nucleus to cytoplasm, 
where it may play a role in pluripotency regulation 
[11, 12]. TgPRMT5 is expressed in both tachyzoite 
and bradyzoite stages, and it is differentially localized 
between these stages, suggesting that TgPRMT5 might 
play a role in tachyzoite-bradyzoite conversion.
Methods
Parasite culture and nucleic extraction
The avirulent Pru∆ku80 (Prugniaud) strain of T. gon-
dii was maintained by serial passage in human foreskin 
fibroblasts (HFF) cultivated in Dulbecco’s modified Eagle 
medium supplemented with 1% (v/v) heat-inactivated 
fetal bovine serum and 25 μg/l gentamicin antibiotic (Life 
Technologies). To induce bradyzoite formation, approxi-
mately 50,000 tachyzoites were inoculated onto conflu-
ent HFF monolayers in T25 flasks with culture medium. 
Two to three hours post-infection, the culture medium 
was replaced with a pH 8.2 medium, which was replaced 
daily. Parasite DNA was isolated from the parasite pel-
let by proteinase K digestion and phenol/chloroform 
extraction.
Plasmid construction and parasite transfection
We modified the endogenous TgPRMT5 genomic locus 
to contain additional sequence at the 3′ end that added a 
3X hemagglutinin (HA) epitope onto the C-terminus of 
TgPRMT5. Pru∆ku80 genomic DNA was used to amplify 
a 1.5 kb fragment at the PRMT5 3′ end using the prim-
ers PRMT5HA_F (5′-TAC TTC CAA TCC AAT TTA 
ATG CGT CTC TAC CAC TGC GTT TTC C-3′) and 
PRMT5HA_R (5′-TCC TCC ACT TCC AAT TTT AGC 
TTT TCC GAT GAA GTAA TGT TT-3′) containing 
ligation-independent cloning sequences (underlined). 
This PRMT5 fragment was inserted into the pLIC_
HAx3_DHFRTs endogenous tagging vector such that 
the TgPRMT5 coding sequence was fused in frame with 
the epitope coding region. The pLIC_PRMT5_HAx3_
DHFRTs construct was confirmed by sequencing. For 
transfection, 30 μg pLIC_PRMT5_HAx3_DHFRTs plas-
mid was linearized by overnight digestion with SgrAI 
within the PRMT5 homologous region followed by 
ethanol precipitation. Pru∆ku80 tachyzoites were trans-
formed with the linearized construct by electroporation. 
Subsequent to overnight growth in the HFF, parasite 
cultures were treated with 1.0 μM pyrimethamine [13]. 
Drug-resistant parasites were cloned by limiting dilution 
and screened using western blot and immunofluores-
cence for expression of HA-tagged TgPRMT5.
Protein expression and purification
Full-length cDNAs encoding TgH3 (TGGT1_261240) 
and TgH4 (TGGT1_239260) were amplified by poly-
merase chain reaction using the primer pairs TgH3_F/
TgH3_R (5′-AAA GAA TTC ATG GCG CGC ACC AAG 
-3′)/(5′-TCC GAG CTC TTA AGA CCG TTC ACC 
AC-3′) and TgH4_F/TgH4_R (5′-AAA GAA TTC ATG 
TCG GGC CGA GGC AAG-3′)/(5′-TCC GAG CTC 
TTA ACC ACC GAA ACC GTA G-3′) and cloned at the 
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EcoRI and SacI sites of vector PET-32a (Novagen, Madi-
son, WI, USA) according to the manufacturer’s instruc-
tions to produce His-TgH3 and His-TgH4. Recombinant 
proteins were expressed in E.coli strain BL21 (DE3). 
Induction was performed by adding 0.1 mM IPTG for 4 
h at 37 °C. Recombinant proteins were purified from 1 l 
of culture using Ni-NTA Fast Start Kit (Sigma-Aldrich, 
Taufkirchen, Germany). Purified recombinant TgH3 and 
TgH4 (rTgH3 and rTgH4) proteins were used for the in 
vitro methylation assay.
Western blot
Tachyzoites were purified from infected HFF monolay-
ers by scraping and passage through an 18G needle 10 
times. Bradyzoites were purified from host cell debris by 
filtration through a 25 mm Nuclepore Track-Etched Poly-
carbonate Membrane circle with a 3.0 µm pore size (GE 
Healthcare, Madison, WI, USA) into a conical tube. Para-
sites were then pelleted by centrifugation and washed 
with cold PBS at 4  °C. Antibody to Toxoplasma BAG1 
(1:1000) was used to detect protein-specific expression 
in the bradyzoites. Toxoplasma β-tubulin expression 
detected by specific polyclonal antibody (1:1000) served 
as a protein loading control. The antibody to BAG1 and 
anti-β-tubulin antibody were provided by Dr David Sib-
ley (Washington University, St. Louis, MO, USA) and 
Dr Louis Weiss (Albert Einstein College of Medicine, 
NY, USA) respectively. To estimate the distribution of 
TgPRMT5 in the cytoplasmic and nuclear compartments 
of parasites, subcellular fractionations were performed 
using the NE-PERTM nuclear and cytoplasmic extrac-
tion kit (Pierce, Rockford, IL, USA) according to the 
manufacturerʼs instructions. Parasite lysates (20 μg) of 
tachyzoites or bradyzoites were separated by SDS/PAGE 
(10%) and transferred to nitrocellulose membranes. 
Western blots were carried out using rat anti-HA anti-
body (Roche, CA, USA) (1:2000) and rabbit anti-H4 anti-
body (Merck  Millipore, Darmstadt,  Germany) (1:1000) 
as primary antibodies and horseradish peroxidase-con-
jugated goat anti-rat IgG (1:3000) and anti-rabbit IgG 
(1:3000) as secondary antibodies. The results were visual-
ized using the ECL detection system (GE Healthcare).
Indirect immunofluorescent assay (IFA)
For IFA, the infected HFF monolayers grown on cov-
erslips were fixed in 4% paraformaldehyde for 20 min 
at room temperature. They were then permeabilized 
for 10 min in PBS containing 3% BSA and 0.2% Triton 
X-100 and blocked for 1 h in PBS with 3% BSA. The 
infected HFF monolayers were first probed with rabbit 
anti-HA antibody (Sigma) (1:500) and anti-BAG1 anti-
body (1:100). Secondary antibodies were FITC-labeled 
anti-rabbit IgG (Sigma-Aldrich, Taufkirchen, Germany) 
and TRITC-labeled anti-mouse IgG (Sigma-Aldrich, 
Taufkirchen, Germany). Fluorescent images were 
obtained using a Nikon ECLIPSE E600 epifluorescence 
microscope.
Immunoprecipitation
To isolate epitope-tagged proteins, immunoprecipita-
tions were performed using parasite lysates. Typically, 
300–500 μg lysate was used for each immunoprecipita-
tion reaction. Rat anti-HA antibody (Roche) was used for 
coupling with the Pierce Crosslink IP Kit (Thermo Fisher 
Scientific, Rockford, IL, USA) according to the manufac-
turer’s instructions. Lysates of the TgPRMT5-HA strain 
were immunoprecipitated with anti-HA antibody. The 
immunoprecipitated complexes were then used for an in 
vitro methylation assay.
In vitro methylation assay
In vitro methylation assays were performed at 30  °C for 
2 h in 20 μl methylation-assay buffer (50 mM Tris-HCl, 
pH 8.5, 20 mM KCl, 10 mM  MgCl2, 1 mM DTT, 250 mM 
sucrose and 1 mM PMSF) containing 5 μg free calf core 
histones (H2A, H2B, H3 and H4) or 2 μg purified thiore-
doxin-6 × His T. gondii core histones H3 (rTgH3) and 
H4 (rTgH4) as substrates and 2 μg purified HA-tagged 
TgPRMT5. Reactions were stopped by the addition of 
LDS sample buffer (4×) and boiling for 5 min. Proteins 
were resolved by SDS/PAGE (15% gel) and transferred 
onto PVDF membranes. Immunoblot assays were per-
formed using the following rabbit polyclonal antibodies: 
anti-monomethyl H3R26 (ab130898; Abcam, CA, USA), 
anti-symmetric dimethyl H3R26 (ab127095; Abcam, 
CA, USA), anti-monomethyl H4R3 (ab17339; Abcam, 
CA, USA), and anti-symmetric dimethyl H4R3 (ab5823; 
Abcam, CA, USA) at 1 μg/ml concentration and horse-
radish peroxidase-conjugated goat anti-rabbit IgG 
(Boster Bio-Tech, Wuhan, China) (1:2000) as the second-
ary antibody. The results were visualized with the ECL 
detection system.
Results
Fusion of HA‑tag to endogenous TgPRMT5
To study the expression and subcellular localization of 
TgPRMT5 in tachyzoites and bradyzoites, we tagged the 
3′ end of the endogenous genomic locus with sequence 
encoding a 3xHA tag in Pru∆ku80 parasites (Fig.  1a). 
Successful tagging of the endogenous TgPRMT5 was 
confirmed by IFA and western blot. Western blot using 
anti-HA antibody detected a specific protein band of 
110 kDa, consistent with the predicted size of TgPRMT5 
(Fig. 1b). By contrast, this protein band was not detected 
in the control wild-type Pru strain parasites. West-
ern blot revealed that TgPRMT5 was expressed in both 
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tachyzoites and bradyzoites with slight enrichment in the 
latter stage (Fig. 1c).
Subcellular localization of TgPRMT5
IFA was performed to check subcellular localiza-
tion of TgPRMT5, and the TgBAG1 was specifically 
expressed in the cytoplasm in the bradyzoite stage as a 
bradyzoite marker. IFA results showed that TgPRMT5 
was localized in the cytoplasm in the tachyzoite stage; 
however, it was mainly localized in the nucleus in 
the bradyzoite stage (Fig.  2a). Further analysis of the 
nuclear-cytoplasmic distribution of TgPRMT5 was 
performed using fractionated parasite lysates (Fig. 2b). 
Parasites were separated into nuclear and cytoplas-
mic fractions, and proteins from each fraction were 
resolved by SDS/PAGE and subjected to immunoblot-
ting. The fidelity of the fractionation was confirmed by 
the predominant detection of histone H4 in the nuclear 
fraction (Fig. 2b). Consistent with the IFA observations, 
TgPRMT5 shifted from cytosolic to nuclear localization 
during conversion to the bradyzoite stage.
Fig. 1 Confirmation of the C‑terminal HA‑tagging of the endogenous TgPRMT5 locus in the Pru strain. a Predicted integration event of HA fusion 
at the endogenous TgPRMT5 locus. Top: TgPRMT5 locus on chromosome X. Grey boxes represent the front part of TgPRMT5 gene; white boxes 
represent the TgPRMT5 region used for homologous recombination in the transfection plasmid; red boxes indicate HAx3‑tagged. Middle: the 
plasmid pLIC_PRMT5_HAx3_DHFRTs. Bottom: The resultant single‑crossover event at the TgPRMT5 locus with integration of one copy of the 
plasmid. b Western blot with anti‑HA antibody that bind to the HA‑tag. The band of 110 kDa was detected in the HA‑tagged TgPRMT5 clone. Lane 
1: clone of HA‑tagged TgPRMT5; Lane 2: wild‑type Pru strain as negative control. c Expression of TgPRMT5 in tachyzoites and bradyzoites. The two 
stages of the parasite were differentiated by antibody against BAG1, a protein expressed specifically in the bradyzoite stage. Anti‑β‑tubulin antibody 
served as a protein loading control
Fig. 2 Subcellular localization of TgPRMT5 in tachyzoites and bradyzoites. a Localization of HA‑TgPRMT5. Representative images of HA‑TgPRMT5 in 
tachyzoites and bradyzoites. Nuclei were stained with DAPI. b Western blots of the parasite nuclear (N) and cytoplasmic (C) fractions, separated by 
10% SDS‑PAGE, and probed with anti‑HA antibody (upper panel), and anti‑H4 antibody (lower panel). Scale-bars: 10 µm
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TgPRMT5 enzyme activity
To determine whether endogenous TgPRMT5 has argi-
nine methyltransferase activity, calf core histones H2A, 
H2B, H3 and H4 as well as purified T. gondii recom-
binant histones H3 and H4 (rTgH3 and rTgH4) were 
used as substrates in the methylation assay. Endogenous 
TgPRMT5-HA was purified using protein A/G beads 
with HA antibody. The purified products were checked in 
the SDS/PAGE gel and stained by Commassie Blue Stain-
ing Solution. The size of the main band was around 110 
kDa, consistent with the predicted size of TgPRMT5-HA 
(Fig.  3a). Specific antibodies were used against mono-
methylated (MMA) and symmetrically dimethylated 
(SDMA) H3R26 or H4R3 to monitor TgPRMT5 activ-
ity by immunoblotting. Endogenous TgPRMT5-HA was 
shown to catalyze both H3R26 and H4R3 monomethyla-
tion and symmetric methylation, consistent with the pre-
diction of this protein as a PRMT5 homolog (Fig. 3b).
Discussion
Arginine methylation governs important cellular pro-
cesses that impact growth, proliferation, differentiation, 
and development [9]. PRMT5 is the major type II meth-
yltransferase and is widely distributed and highly con-
served [14]. Unique among the PRMTs, PRMT5 works 
in concert with other cellular proteins including ATP-
dependent chromatin remodelers and co-repressors to 
induce epigenetic silencing. Furthermore, PRMT5 has 
recently been implicated in control of growth-promoting 
and pro-survival pathways, thereby demonstrating its 
versatile enzymatic roles in epigenetic regulation of anti-
cancer target genes and organelle biogenesis [9].
In the present study, we presented biochemical evi-
dence demonstrating that TgPRMT5 has intrinsic type 
II PRMT activity, catalyzing the formation of MMA and 
SDMA. In the histone H4 N-terminus, TgPRMT5 can 
symmetrically methylate  Arg3, a transcription repres-
sion marker [15]. These findings suggest that TgPRMT5 
protein is a PRMT5 homolog and may participate in gene 
repression in T. gondii. TgPRMT5 was expressed in the 
tachyzoite and bradyzoite stages of the parasite, with the 
protein localization in cytoplasm in tachyzoites; how-
ever, it mainly localized in the nucleus in bradyzoites. In 
mammals, localization of PRMT5 differs between non-
transformed and transformed cells. In most primary and 
immortalized cells, PRMT5 is primarily located in the 
cytosol with small amounts in the nucleus. In contrast, 
this distribution is reversed in transformed cells [16–18]. 
Therefore, PRMT5 localization and the substrates it tar-
gets in each cellular compartment appear to play a cru-
cial role in the control of cell growth and proliferation. 
The differential subcellular localization of TgPRMT5 in 
tachyzoites and bradyzoites suggests that it may play a 
role in tachyzoite-bradyzoite conversion.
Conclusions
In present study, we determined the expression and cel-
lular localization of TgPRMT5 in tachyzoites and brady-
zoites and confirmed its type II PRMT activity. We 
demonstrated the major changes in expression and cel-
lular localization of TgPRMT5 during the tachyzoite and 
bradyzoite stages in T. gondii. These findings will provide 
a novel insight into addressing the mechanism of tachy-
zoite-bradyzoite transformation.
Fig. 3 In vitro methylation of histones by purified HA‑tagged endogenous TgPRMT5. a The HA‑tagged endogenous TgPRMT5 were purified with 
an anti‑HA antibody and checked in SDS/PAGE. b Immunoprecipitations using an anti‑HA antibody were performed on parasite lysates made from 
TgPRMT5‑HA and the parental Pru∆ku80 line. The immunoprecipitated products were used in vitro methylation assays with T. gondii recombinant 
histones H3/H4 (rTgH3 and rTgH4) and calf core histones as substrates or without substrates (blank), and the reactions were separated by SDS/PAGE 
(15% gel). Immunoblots were performed using rabbit polyclonal antibodies as follows: anti‑monomethyl H3R26, anti‑symmetric dimethyl H3R26, 
anti‑monomethyl H4R3 and anti‑symmetric dimethyl H4R3
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